Literature DB >> 1988454

Activation of messenger-independent protein kinases in wild-type and phorbol ester-resistant EL4 thymoma cells.

K E Meier1, K A Licciardi, T A Haystead, E G Krebs.   

Abstract

Phorbol esters, acting via activation of the protein kinase C family of protein serine/threonine kinases, are able to exert profound effects on various cellular functions. In this study, we used the EL4 thymoma cell line to study the potential role of "downstream" protein serine/threonine kinases in cellular responses to phorbol esters. In wild-type EL4 cells, addition of phorbol ester caused a rapid activation of kinase activity toward RRLSSLRA (S6P). This increased activity was maintained for at least 15 min but diminished to control levels by 60 min. Activation of a myelin basic protein (MBP) kinase was also seen in response to phorbol ester. In a variant EL4 cell line in which phorbol ester does not induce interleukin 2 transcription, phorbol ester failed to activate either the S6P kinase or MBP kinase. Partial purification of the activated S6P and MBP kinases from wild-type cells showed that they represent separate enzymes that are distinct from protein kinase C. Although the variant cells had reduced levels of protein kinase C as compared with the wild-type cells, the amount of membrane-bound enzyme increased in response to phorbol 12-myristate 13-acetate in both wild-type and variant cells. Treatment of intact cells with phorbol ester resulted in phosphorylation of some of the same protein substrates in both cell lines. Okadaic acid, a phosphatase inhibitor, increased S6P and MBP kinase activities in both wild-type and variant cells. Thus, phorbol ester failed to activate the S6P and MBP kinases in the variant cells even though these cells express activatable protein kinase C, S6P kinase, and MBP kinase. Two protein kinase inhibitors, staurosporine and H-7, inhibited the activity of all three kinases in vitro, while a peptide inhibitor (PKC 19-31) showed specificity for protein kinase C. In summary, these results suggest that activation of messenger-independent protein kinases may be critical for certain protein kinase C-dependent responses.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1988454

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  p42/mitogen-activated protein kinase as a converging target for different growth factor signaling pathways: use of pertussis toxin as a discrimination factor.

Authors:  G L'Allemain; J Pouyssegur; M J Weber
Journal:  Cell Regul       Date:  1991-08

2.  Immunodetection of activated mitogen-activated protein kinase in vascular tissues.

Authors:  L Yau; P Zahradka
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

3.  Temperature-dependent tyrosine phosphorylation of microtubule-associated protein kinase in epidermal growth factor-stimulated human fibroblasts.

Authors:  R Campos-González; J R Glenney
Journal:  Cell Regul       Date:  1991-08

Review 4.  Networking with mitogen-activated protein kinases.

Authors:  S L Pelech; D L Charest; G P Mordret; Y L Siow; C Palaty; D Campbell; L Charlton; M Samiei; J S Sanghera
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

5.  Differential expression of FAK and Pyk2 in metastatic and non-metastatic EL4 lymphoma cell lines.

Authors:  Zhihong Zhang; Stewart M Knoepp; Hsun Ku; Heather M Sansbury; Yuhuan Xie; Manpreet S Chahal; Stephen Tomlinson; Kathryn E Meier
Journal:  Clin Exp Metastasis       Date:  2011-05-01       Impact factor: 5.150

6.  Time-resolved phosphoproteome and proteome analysis reveals kinase signaling on master transcription factors during myogenesis.

Authors:  Di Xiao; Marissa Caldow; Hani Jieun Kim; Ronnie Blazev; Rene Koopman; Deborah Manandi; Benjamin L Parker; Pengyi Yang
Journal:  iScience       Date:  2022-05-30

7.  Effect of UCN-01, a selective inhibitor of protein kinase C, on the cell-cycle distribution of human epidermoid carcinoma, A431 cells.

Authors:  S Akinaga; K Nomura; K Gomi; M Okabe
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

8.  Contrasting effects of two tumour promoters, phorbol myristate acetate and okadaic acid, on T-cell responses and activation of p42 MAP-kinase/ERK-2.

Authors:  M C Amaral; A M Casillas; A E Nel
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

9.  Epidermal growth factor stimulates the disruption of gap junctional communication and connexin43 phosphorylation independent of 12-0-tetradecanoylphorbol 13-acetate-sensitive protein kinase C: the possible involvement of mitogen-activated protein kinase.

Authors:  M Y Kanemitsu; A F Lau
Journal:  Mol Biol Cell       Date:  1993-08       Impact factor: 4.138

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.